CDK8 and leiomyoma: In the absence of GnRH treatment, MED12 WT leiomyomas exhibited significantly higher CDK8 activity than MED12 MUT leiomyomas (p = 0.02, Kruskal–Wallis test with Dunn’s post-hoc analysis).